The actual device was not returned to the manufacturing facility for evaluation and the lot number is unknown.Therefore, the investigation was based upon evaluation of user facility information and testing of a product sample.A fx05 oxygenator sample was built into a circuit at the room temperature of 20 degrees celsius.The 500 ml of saline solution was put into the whole body of the circuit.With the circulation of hot water at 37 degrees celsius in the heat exchanger, saline solution was circulated in the main circuit at the flow rate of 1.5 l/min.Then the circulation in the main circuit was stopped.It was noted, approximately 40 seconds later, the temperature was determined with the thermistor probe set at the venous blood inlet port decreased by approximately 2 degrees celsius.The temperature was determined at the blood outlet port on the oxygenator module also decreased with a time difference.A fx05 oxygenator sample was built into a circuit at the room temperature of 20 degrees celsius 500 ml of saline solution was put into the whole body of the circuit.With the circulation of hot water at 37 degrees celsius in the heat exchanger, saline solution was circulated in the main circuit at the flow rate of 1.5 l/min.Then the flow rate in the main circuit was reduced to 0.1 l/min.It was noted, approximately three minutes later, the temperature was determined at the venous blood inlet port had decreased by approximately 2 degrees celsius.There was little change in the temperature determined at the blood outlet port on the oxygenator module.Based on the investigation results, it is likely that the fluid contained in the circuit became cooled down by the room temperature.The exact cause of the reported event cannot be definitively determined.There are many complex clinical variables that may have affected the reportedly observed conditions during the procedure.However, there is no indication that the reported event was related to a product defect or malfunction.The production lot number was not provided by the user facility, which prevented a meaningful review of the device history record and complaint files.(b)(4).All available information has been placed on file in quality assurance for appropriate tracking, trending and follow-up.
|